Farahany serves as Alda’s legal and bioethical correspondent throughout the two-part series that examines the question of whether emerging brain-scanning technology might become courtroom evidence about a person's state of mind, thoughts and memories. She even underwent an MRI for the series, which will air at 10 p.m. ET on Sept. 11 and Sept. 18 on PBS-affiliate stations.
A leading scholar on the ethical, legal, and social implications of biosciences and emerging technologies, particularly those related to neuroscience and behavioral genetics, Farahany is a member of the Presidential Commission for the study of Bioethical Issues. She holds joint appointments at Duke Law School and Duke University’s Institute for Genome Sciences & Policy and a secondary appointment in the Department of Philosophy. She received her AB in genetics, cell, and developmental biology at Dartmouth College, a JD and MA from Duke University, as well as a PhD in philosophy; her dissertation was entitled “Rediscovering Criminal Responsibility through Behavioral Genetics.” Farahany also holds an ALM in biology from Harvard University.
Alda will lead a discussion in the Nasher Museum Auditorium about neuroscience and the law with Farahany and Duke professors Scott Huettel, Walter Sinnott-Armstrong and Ahmad Hariri on Sept. 11. The invitation-only event, sponsored by Duke University, is being taped by UNC-TV for broadcast at 10 p.m. on Thursday, Sept. 12.
“Brains on Trial” is produced by WNEY in New York.